...
首页> 外文期刊>Respiratory medicine >A randomized trial of auto-titrating CPAP and fixed CPAP in the treatment of obstructive sleep apnea-hypopnea.
【24h】

A randomized trial of auto-titrating CPAP and fixed CPAP in the treatment of obstructive sleep apnea-hypopnea.

机译:自动滴定CPAP和固定CPAP治疗阻塞性睡眠呼吸暂停低通气的随机试验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Continuous positive airway pressure (CPAP) remains the treatment of choice for obstructive sleep apnea hypopnea (OSAH). Auto-titrating CPAP (APAP) devices automatically adjust pressure and may improve treatment compliance compared to fixed CPAP (F-CPAP). METHODS: Randomized, prospective, single-blind, crossover trial to compare efficacy, side effects, compliance, patient satisfaction and preference between APAP and F-CPAP therapy in patients with moderate to severe OSAH. There were two treatment periods of 4 weeks each (APAP and F-CPAP), separated by a 2-week washout period. RESULTS: Ten CPAP-naive OSAH patients (9 males) completed the study. They had Mean +/- SD age of 44.9 +/- 9.7 years; body mass index of 35.9 +/- 12.9 kg/m2 and apnea/hypopnea index (AHI) of 47.2 +/- 35.6. Both forms of therapy were equally effective in improving the symptoms and in reducing the AHI. Both forms of therapy were associated with frequent side effects and had similar patient compliance. At the end of the study, more patients (6-1) preferred F-CPAP to A-CPAP therapy. CONCLUSION: A-PAP was as effective as F-CPAP in the treatment of OSAH but was not associated with fewer side effects, better compliance, better satisfaction or increased patient preference.
机译:背景:持续的气道正压通气(CPAP)仍然是阻塞性睡眠呼吸暂停低通气(OSAH)的治疗选择。与固定式CPAP(F-CPAP)相比,自动滴定CPAP(APAP)设备可自动调节压力并可以改善治疗依从性。方法:一项随机,前瞻性,单盲,交叉试验,比较中度至重度OSAH患者的APAP和F-CPAP治疗之间的疗效,副作用,依从性,患者满意度和偏好。有两个疗程,每个疗程为4周(APAP和F-CPAP),相隔2周的冲洗期。结果:10例未接受过CPAP的OSAH患者(9例男性)完成了研究。他们的平均+/- SD年龄为44.9 +/- 9.7岁;体重指数为35.9 +/- 12.9 kg / m2,呼吸暂停/呼吸不足指数(AHI)为47.2 +/- 35.6。两种疗法在改善症状和降低AHI方面均有效。两种疗法均与频繁的副作用相关,并且患者依从性相似。在研究结束时,更多的患者(6-1)首选F-CPAP而非A-CPAP治疗。结论:A-PAP在OSAH的治疗中与F-CPAP一样有效,但并没有带来更少的副作用,更好的依从性,更好的满意度或增加的患者偏爱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号